Federal Prime Contractor Profile
Large Enterprise Prime
MODERNATX, INC.
UEI:WJYNZ8AK2D47
CAGE:24450
Washington, MA 02139
MODERNATX, INC. is a federal contractor providing Computer Systems Design Services to departments including the Department of Defense.
Executive Summary
Verified SAM.gov & FPDS DataBetween 2018 and 2026, MODERNATX, INC. captured $1.75B across federal task orders and definitive prime awards, recording $614.0M in trailing 12-month obligations. Its primary federal customer is the Department of Defense (60% of total obligations), while maintaining an overall historical recompete retention rate of 81.5% with an average award cycle of 51 days.
•Top Agency: Department of Defense (60% share)
•Recompete Retention: 81.5%
•Average Award Cycle: 51 Days
•Primary Industry: NAICS 541512 (Computer Systems Design Services)
•Active Task Orders: 1
•Competition Profile: 2.8 avg bidders
Lifetime Federal Obligations
$1.75B
Cumulative prime contract awards
Trailing 12-Month Spend
$614.0M
Recent annualized award velocity
Recompete Retention Rate
81.5%
Historical recompete win rate
Average Award Cycle
51 Days
RFP release to definitive award
Prime vs. Sub Ratio
85% Prime
15% Subcontractor work
Average Bid Competition
2.8 Bidders
Average competing offers received
Agency Contracting Breakdown
Historical performance, award volumes, and recompete retention by federal agency.
DHAView Agency Analytics
MODERNATX, INC. × Defense Health Agency
View task orders, vehicle wins, and delivery history.
DoDView Agency Analytics
MODERNATX, INC. × Department of Defense
View task orders, vehicle wins, and delivery history.
VAView Agency Analytics
MODERNATX, INC. × Department of Veterans Affairs
View task orders, vehicle wins, and delivery history.
Major Prime Contract Awards & Vehicles
Active definitive awards and delivery orders recorded in federal procurement databases.
| Award PIID / Vehicle | Awarding Agency | Competition Type | Period of Performance | Obligated Amount |
|---|---|---|---|---|
75A50120C00034 DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT | Department of Health and Human Services Definitive Contract | Full and Open Competition 4 bidders | Apr 3, 2020 to Jun 15, 2025 | $1.75B Potential Value: $2.63B |